Natco Launches Generic Blood Cancer Drug


Natco has announced the launch of a generic version of pomalidomide capsules for the Indian market. The drugs are used to treat Myeloma, a form of blood cancer. The branded version of the drug is sold by Celgene under the POMALYST name. Natco released a statement that their generic version of the drug will be sold at a 98 percent discount from what it is sold at in the US.

Read the source article at LiveMint

About the Author

Related Posts

Leave a Reply